Combined use of the ELF test and CLivD score improves prediction of liver‐related outcomes in the general population

医学 内科学 弗雷明翰风险评分 人口 风险评估 糖尿病 肝病 疾病 环境卫生 内分泌学 计算机安全 计算机科学
作者
Fredrik Åberg,Kustaa Saarinen,Antti Jula,Annamari Lundqvist,Terhi Vihervaara,Iris Erlund,Martti Färkkilâ
出处
期刊:Liver International [Wiley]
卷期号:43 (10): 2107-2115 被引量:1
标识
DOI:10.1111/liv.15681
摘要

Abstract Background and Aims Effective and feasible population screening strategies are needed for the early detection of individuals at high risk of future severe liver‐related outcomes. We evaluated the predictive performance of the combination of liver fibrosis assessment, phenotype profile, and genetic risk. Methods Data from 5795 adults attending the Finnish Health 2000 Survey were linked with healthcare registers for liver‐related outcomes (hospitalization, hepatocellular cancer, and death). Fibrosis was assessed using the enhanced liver fibrosis (ELF) test, phenotype profile by the chronic liver disease (CLivD) risk score, and genetic risk by a validated Polygenic Risk Score (PRS‐5). Predictive performance was assessed by competing‐risk analyses. Results During a median 13‐year follow‐up, 64 liver‐related outcome events were recorded. ELF, CLivD score, and PRS‐5 were independently associated with liver‐related outcomes. The absolute 10‐year risk of liver‐related outcomes at an ELF value of 11.3 ranged from 0.3% to 33% depending on the CLivD score. The CLivD score added 51% of new predictive information to the ELF test and improved areas under the curve (AUCs) from 0.91, 0.81, and 0.71 for ELF alone to 0.95, 0.85, and 0.80, respectively, for ELF combined with the CLivD score at 1, 5, and 10 years. The greatest improvement was for 10‐year predictions (delta‐AUC 0.097, p < .0001). Adding PRS‐5 did not significantly increase predictive performance. Findings were consistent in individuals with obesity, diabetes, or alcohol risk use, and regardless of whether gamma‐glutamyltransferase was used in the CLivD score. Conclusion A combination of ELF and CLivD score predicts liver‐related outcomes significantly better than the ELF test alone.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
akea123完成签到,获得积分10
刚刚
小二郎的应助被Xiaoab采纳,获得10
刚刚
少双发布了新的文献求助10
1秒前
ding的应助被威威采纳,获得10
1秒前
无花果的应助被爱吃糖葫芦采纳,获得10
1秒前
1秒前
满意的遥发布了新的文献求助10
1秒前
打打的应助被舒适平文采纳,获得10
1秒前
Ava的应助被司空白安采纳,获得10
2秒前
Akim的应助被ycy采纳,获得10
2秒前
摄氏度26完成签到,获得积分10
2秒前
2秒前
七七发布了新的文献求助10
2秒前
徐昊楠完成签到,获得积分10
2秒前
张卓情发布了新的文献求助10
2秒前
叫我滚球兽就好了完成签到,获得积分10
3秒前
xxxxx发布了新的文献求助10
3秒前
4秒前
qianjiu完成签到,获得积分10
4秒前
机智大船发布了新的文献求助10
4秒前
4秒前
zhen完成签到,获得积分20
4秒前
李爱国的应助被阳阳阳采纳,获得10
5秒前
Maestro_S的应助被wenyu_Tan采纳,获得10
5秒前
5秒前
沉静的友灵完成签到,获得积分10
6秒前
科研通AI6.4的应助被akea123采纳,获得10
6秒前
脑洞疼的应助被spark采纳,获得10
6秒前
6秒前
516165165完成签到,获得积分10
6秒前
7秒前
hunbaekkkkk发布了新的文献求助10
7秒前
彭于晏的应助被飞行雪绒采纳,获得10
8秒前
zhen发布了新的文献求助10
8秒前
共享精神的应助被飞行雪绒采纳,获得10
8秒前
标致的凝安完成签到,获得积分10
8秒前
kaku完成签到,获得积分10
8秒前
丁真珍珠发布了新的文献求助10
8秒前
传奇3的应助被张卓情采纳,获得10
8秒前
JamesPei的应助被小徐采纳,获得10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8162138
求助须知:如何正确求助?哪些是违规求助? 9556501
关于积分的说明 21735379
捐赠科研通 7752349
什么是DOI,文献DOI怎么找? 3427639
关于科研通互助平台的介绍 2552678
邀请新用户注册赠送积分活动 2472242